Anavex Life Sciences (AVXL) Tops Q4 EPS by 3c

Anavex Life Sciences (NASDAQ: AVXL) reported Q4 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold